The Rotavirus Vaccine: A Case Study in Government Corruption and Malfeasance

The Rotavirus Vaccine: A Case Study in Government Corruption and Malfeasance

The major media dismiss public vaccine policy critics as “conspiracy theorists”, but no conspiracy is required to explain how it can be true that the CDC deceives about vaccines.

 

By Jeremy R. Hammond, Children’s Health Defense Contributing Writer

In a previous article for Children’s Health Defense, titled “Why You Can’t Trust the CDC on Vaccines”, we looked at how it can be true that government agencies are misinforming the public about the safety and effectiveness of vaccines. The very prospect is treated by the mainstream corporate media as a “conspiracy theory”, but no such theory is required to explain it. On the contrary, the existence of institutionalized biases within the medical establishment and scientific community are well recognized in the scientific literature, and the Congress itself has criticized the endemic corruption within the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA).

…a particularly salient example of government corruption and malfeasance: the case of the rotavirus vaccine.

For example, we saw how both agencies were criticized by the June 2000 report of an investigation initiated by the Committee on Government Reform within the House of Representatives. That investigation touched on a particularly salient example of government corruption and malfeasance: the case of the rotavirus vaccine.

Among the Congressional investigation’s findings were that three out of five members of the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) “who voted to approve the rotavirus vaccine in December 1997 had financial ties to pharmaceutical companies that were developing different versions of the vaccine”, while four out of eight members of the CDC’s Advisory Committee on Immunization Practices (ACIP) “who voted to approve guidelines for the rotavirus vaccine in June 1998 had financial ties to pharmaceutical companies that were developing different versions of the vaccine”.

Included among the half of ACIP members who had financial ties to pharmaceutical companies while deliberating what CDC policy should be with respect to the rotavirus vaccine was one Dr. Paul Offit…. Read More